Answers are grounded in this paper and cite their sources.
Implantable atrial defibrillators are not recommended as a standalone therapy for atrial fibrillation but may have a role as part of a hybrid strategy.
The role of devices that deliver shock therapy for atrial fibrillation is still debated. Following technical improvements in catheter-based atrial defibrillation, implantable devices have become available either in the form of stand-alone atrial defibrillators or in the form of dual defibrillators. Although preliminary results do not support their use as a single, unique treatment for atrial fibrillation patients, in combination with drugs, pacing or other treatments such as ablation, atrial defibrillators should help appropriately selected groups of patients.
No takes yet. Share an insight, caveat, or question.
Boriani et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: